Cristina López
Research group
- Molecular pathology of lymphoid neoplasms Assistant researcher (R2C)
About me
The research of Dr. López has targeted the identification of chromosomal aberrations in B and T cell neoplasias. She performed her PhD in Tumorcytogenetic Department of Hospital Clinic of Barcelona under Dr. Carrió and Dr. Colomer supervision, and was focused in the detection of chromosomal abnormalities associated to different subtypes of chronic lymphocytic leukemia. In the meanwhile, she was awarded with a predoctoral grant from Institute Carlos III (2008-2012). Thereafter, she continued her research career with a postdoctoral program in Germany with the group of Prof. Reiner Siebert. She was awarded with the Alexander von Humboldt Foundation grant (2013-2015). During the last years she was mainly focused in the context of the International Cancer Genome Consortium (ICGC) MMML-Seq proje
Featured publications
-
Genomic and epigenomic insights into the origin, pathogenesis and clinical behavior of mantle cell lymphoma subtypes
Authors:Reference: Blood 2020. -
Mesenchymal Hamartoma of the Liver and DICER1 Syndrome
Authors:Reference: New England Journal Of Medicine 2019. -
Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma
Authors:Reference: Nature Communications 2019. -
IG-MYC plus neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas
Authors:Reference: Blood 2018. -
B-cell-specific conditional expression of Myd88(p.L252P) leads to the development of diffuse large B-cell lymphoma in mice
Authors:Reference: Blood 2016. -
Genes encoding members of the JAK-STAT pathway or epigenetic regulators are recurrently mutated in T-cell prolymphocytic leukaemia
Authors:Reference: British Journal Of Haematology 2016. -
DNA methylome analysis in Burkitt and follicular lymphomas identifies differentially methylated regions linked to somatic mutation and transcriptional control
Authors:Reference: Nature Genetics 2015.